Treefrog Therapeutics Secures $75M In Series B Financing To Advance A Pipeline Of Stem Cell-Derived Cell Therapies And Deploy Proprietary C-Stem™ Technology In The Usa & Japan
Amount Raised
$75 Million
Round Type
Series B
BordeauxBiotechnologyDescription
TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75 million (€64M) Series B financing round, bringing the total funding to date to $83 million (€70M). The financing round was led by Bpifrance Large Venture, part of the French Public Investment Bank, joined by U.S. investment firm Leonard Green & Partners L.P., global pharmaceutical company Bristol Myers Squibb, and European venture capital team XAnge. In conjunction with the financing, independent board member Frederic Desdouits, PhD, has been appointed chief executive officer
Who else raised in Biotechnology around the same time
Companies in the same sectors as TreeFrog Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cage Bio raised $11M on October 28, 2021.
- Protego Biopharma raised $51M on October 28, 2021.
- Sphere Fluidics raised $40M (Funding Round) on October 28, 2021.
- Holobiome raised $1M (Seed) on October 28, 2021.
- SummaCor, Inc. raised $3.5M (Seed) on October 28, 2021.
- Resonant Therapeutics, Inc. raised $2.5M (Seed) on October 28, 2021.
Who to call at TreeFrog Therapeutics, and when
A new round usually means TreeFrog Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TreeFrog Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TreeFrog Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TreeFrog Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TreeFrog Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTreeFrog Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.